Virology
Hepatitis B virus mutants induce apoptosis in tree shrew liver cells
Published in Hepatitis Weekly, March 28th, 2005
According to recent research from Germany, "hepatitis B virus (HBV) core promoter mutations have been implicated in the pathogenesis of fulminant hepatitis B. Due to the limited availability of primary human hepatocytes, the functional characterization of HBV mutants has been performed predominantly in transformed cells, which may not represent ideal model systems for studying virus-cell interactions."
"We and others have shown that primary hepatocytes of the tree shrew Tupaia belangeri support HBV infection and replication," T.F. Baumert and colleagues, University of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2005-03-28)
More Articles from Hepatitis Weekly
- Addiction Medicine
MELD scores forecast mortality in patients with alcoholic hepatitis - Diagnostics
Glycoproteomic analysis discovers markers for early HBV-related liver cancer - Drug Delivery
HepDirect prodrugs guide therapy to liver cells - Hepatitis B Therapy
Short hairpin RNA clears hepatitis B virus from murine livers - Virology
Hepatitis C can persist in patients deemed sustained virological responders - Addiction Medicine
Injection drug use status influences HCV-related referral and treatment - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
